{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:28:39Z","timestamp":1782358119097,"version":"3.54.5"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017506","name":"Alzheimer\u2019s Society","doi-asserted-by":"publisher","award":["grant no. P75464"],"award-info":[{"award-number":["grant no. P75464"]}],"id":[{"id":"10.13039\/501100017506","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research (NIHR) Biomedical Research Centre at Imperial College London"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Episodic memory impairment and brain amyloid-beta are two of the main hallmarks of Alzheimer\u2019s Disease. In the clinical setting, these are often evaluated through neuropsychological testing and amyloid PET imaging, respectively. The use of amyloid PET in clinical practice is only indicated in patients with substantial diagnostic uncertainty due to atypical clinical presentation, multiple comorbidities and\/or early age of onset. The relationship between amyloid-beta and cognition has been previously investigated, but no study has examined how neuropsychological features relate to the presence of amyloid pathology in the clinical population that meets the appropriate use criteria for amyloid PET imaging. In this study, we evaluated a clinical cohort of patients (n\u2009=\u2009107) who presented at the Imperial Memory Clinic and were referred for clinical amyloid PET and neuropsychological assessment as part of their diagnostic workup. We compared the cognitive performance of amyloid-positive patients (A\u03b2-pos, n\u2009=\u200947) with that of stable amyloid-negative (stableA\u03b2-neg, n\u2009=\u200926) and progressive amyloid-negative (progA\u03b2-neg, n\u2009=\u200934) patients. The amyloid-positive group performed significantly worse than both amyloid-negative groups in the visuospatial and working memory domains. Episodic memory performance, however, effectively differentiated the amyloid-positive group from the stable but not the progressive amyloid-negative group. On affective questionnaires, the stable amyloid-negative group reported significantly higher levels of depression than the amyloid-positive group. In our clinical cohort, visuospatial dysfunction and working memory impairment were better indicators of amyloid positivity than episodic memory dysfunction. These findings highlight the limited value of isolated cognitive scores in patients with atypical clinical presentation, comorbidities and\/or early age of onset.<\/jats:p>","DOI":"10.1093\/braincomms\/fcab035","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T20:13:42Z","timestamp":1615407222000},"source":"Crossref","is-referenced-by-count":14,"title":["Evaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging"],"prefix":"10.1093","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-9727","authenticated-orcid":false,"given":"Flavia","family":"Loreto","sequence":"first","affiliation":[{"name":"Department of Brain Sciences, Faculty of Medicine, Imperial College London, London W6 8RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gunning","sequence":"additional","affiliation":[{"name":"Department of Neuropsychology, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Golemme","sequence":"additional","affiliation":[{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Watt","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Public Health, Faculty of Medicine, Imperial College London, London W6 8RP, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarni","family":"Win","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Carswell","sequence":"additional","affiliation":[{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"Perry","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Faculty of Medicine, Imperial College London, London W6 8RP, UK"},{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London W6 8RF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-0780","authenticated-orcid":false,"given":"Paresh A","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences, Faculty of Medicine, Imperial College London, London W6 8RP, UK"},{"name":"Department of Neurology, Imperial College Healthcare NHS Trust, London W6 8RF, UK"},{"name":"UK Dementia Research Institute Care Research and Technology Centre, Imperial College London and the University of Surrey, London W12 0NN, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"issue":"4","key":"2021060422122441000_fcab035-B1","doi-asserted-by":"crossref","first-page":"a006171","DOI":"10.1101\/cshperspect.a006171","article-title":"The neuropsychological profile of Alzheimer disease","volume":"2","author":"Weintraub","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"2021060422122441000_fcab035-B2","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/brain\/awy282","article-title":"Exploring Alzheimer\u2019s disease subtypes at the prodromal stage","volume":"141","author":"Kolanko","year":"2018","journal-title":"Brain"},{"issue":"8","key":"2021060422122441000_fcab035-B3","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jalz.2017.01.014","article-title":"Consensus classification of posterior cortical atrophy","volume":"13","author":"Crutch","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2021060422122441000_fcab035-B4","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"2021060422122441000_fcab035-B5","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa068","article-title":"Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes","volume":"2","author":"Townley","year":"2020","journal-title":"Brain Commun"},{"issue":"3","key":"2021060422122441000_fcab035-B6","first-page":"38","article-title":"Rate of early onset Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Ann Transl Med Mar"},{"issue":"3","key":"2021060422122441000_fcab035-B7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"2021060422122441000_fcab035-B8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet"},{"issue":"1101","key":"2021060422122441000_fcab035-B9","doi-asserted-by":"crossref","first-page":"20181027","DOI":"10.1259\/bjr.20181027","article-title":"Clinical (18)F-FDG and amyloid brain positron emission tomography\/CT in the investigation of cognitive impairment: Where are we now?","volume":"92","author":"Dumba","year":"2019","journal-title":"Br J Radiol"},{"issue":"1","key":"2021060422122441000_fcab035-B10","doi-asserted-by":"crossref","first-page":"e-1","DOI":"10.1016\/j.jalz.2013.01.002","article-title":"Appropriate use criteria for amyloid PET: A report of the amyloid imaging task force, the Society of nuclear medicine and molecular imaging, and the Alzheimer\u2019s association","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"2021060422122441000_fcab035-B11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.dadm.2018.02.008","article-title":"Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients","volume":"10","author":"Tomadesso","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"2021060422122441000_fcab035-B12","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-142943","article-title":"Alzheimer\u2019s disease neuroimaging I. Neuropsychological testing predicts cerebrospinal fluid amyloid-beta in mild cognitive impairment","volume":"46","author":"Kandel","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2021060422122441000_fcab035-B13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of cerebral amyloid-beta aggregation with cognitive functioning in persons without dementia","volume":"75","author":"Jansen","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"2021060422122441000_fcab035-B14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1037\/a0032321","article-title":"Cognitive consequences of high Abeta amyloid in mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer\u2019s disease","volume":"27","author":"Lim","year":"2013","journal-title":"Neuropsychology"},{"key":"2021060422122441000_fcab035-B15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2019.01.017","article-title":"Is there a specific memory signature associated with Abeta-PET positivity in patients with amnestic mild cognitive impairment?","volume":"77","author":"Tomadesso","year":"2019","journal-title":"Neurobiol Aging"},{"key":"2021060422122441000_fcab035-B16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/practneurol-2019-002468","article-title":"Amyloid PET imaging in clinical practice","volume":"20","author":"Kolanko","year":"2020","journal-title":"Pract Neurol"},{"key":"2021060422122441000_fcab035-B17","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/WNL.0b013e31821a44dd","article-title":"Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease","volume":"76","author":"Balasa","year":"2011","journal-title":"Neurology"},{"key":"2021060422122441000_fcab035-B18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"2021060422122441000_fcab035-B19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1474-4422(20)30002-8","article-title":"Subjective cognitive decline: What is it good for?","volume":"19","author":"Howard","year":"2020","journal-title":"Lancet Neurol"},{"key":"2021060422122441000_fcab035-B20","author":"McKenna","year":"1983"},{"key":"2021060422122441000_fcab035-B21","author":"Wechsler","year":"2009"},{"key":"2021060422122441000_fcab035-B22","volume-title":"Delis-Kaplan executive function system: Technical manual","author":"Delis","year":"2001"},{"key":"2021060422122441000_fcab035-B23","volume-title":"Wechsler adult intelligence scale-IV","author":"Weschsler","year":"2008"},{"issue":"6","key":"2021060422122441000_fcab035-B24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"2021060422122441000_fcab035-B25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.copsyc.2018.11.002","article-title":"Impairments of attention in Alzheimer\u2019s disease","volume":"29","author":"Malhotra","year":"2019","journal-title":"Curr Opin Psychol"},{"key":"2021060422122441000_fcab035-B26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.dadm.2017.10.004","article-title":"Can visuospatial measures improve the diagnosis of Alzheimer\u2019s disease?","volume":"10","author":"Salimi","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"2021060422122441000_fcab035-B27","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1002\/hbm.22927","article-title":"Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer\u2019s disease","volume":"36","author":"Ossenkoppele","year":"2015","journal-title":"Hum Brain Mapp."},{"issue":"2","key":"2021060422122441000_fcab035-B28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/pne0000140","article-title":"Digit span sequencing as a neurocognitive screening tool in an aging, veteran population","volume":"12","author":"Lumpkin","year":"2019","journal-title":"Psychol Neurosci"},{"issue":"3","key":"2021060422122441000_fcab035-B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/1980-57642015dn93000014","article-title":"Assessment of verbal and visuospatial working memory in mild cognitive impairment and Alzheimer\u2019s dementia","volume":"9","author":"Kessels","year":"2015","journal-title":"Dement Neuropsychol"},{"issue":"4","key":"2021060422122441000_fcab035-B30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"15","key":"2021060422122441000_fcab035-B31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1212\/01.wnl.0000277459.83543.99","article-title":"The significance of medial temporal lobe atrophy. A postmortem MRI study in the very old","volume":"69","author":"Barkhof","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"2021060422122441000_fcab035-B32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JAD-122293","article-title":"Is hippocampal volume a good marker to differentiate Alzheimer\u2019s disease from frontotemporal dementia?","volume":"36","author":"de Souza","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"2021060422122441000_fcab035-B33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"2021060422122441000_fcab035-B34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3233\/JAD-180646","article-title":"The incremental diagnostic value of [18F]Florbetaben PET and the pivotal role of the neuropsychological assessment in clinical practice","volume":"67","author":"Spallazzi","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"2021060422122441000_fcab035-B35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fnagi.2019.00095","article-title":"Alzheimer\u2019s disease neuroimaging I. Cognitive profiling related to cerebral amyloid beta burden using machine learning approaches","volume":"11","author":"Ko","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"2021060422122441000_fcab035-B36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.psych.57.102904.190024","article-title":"Neuropsychological assessment of dementia","volume":"60","author":"Salmon","year":"2009","journal-title":"Annu Rev Psychol"},{"key":"2021060422122441000_fcab035-B37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"2021060422122441000_fcab035-B38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1017\/S0033291718002829","article-title":"Longitudinal outcomes of patients with pseudodementia: A systematic review","volume":"49","author":"Connors","year":"2018","journal-title":"Psychol Med"},{"issue":"1","key":"2021060422122441000_fcab035-B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2019.98","article-title":"Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer\u2019s disease and vascular dementia?","volume":"216","author":"Savulich","year":"2019","journal-title":"Br J Psychiatr"},{"key":"2021060422122441000_fcab035-B40","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/01.WNL.0000055813.36504.BF","article-title":"Visual memory predicts Alzheimer\u2019s disease more than a decade before diagnosis","volume":"60","author":"Kawas","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"2021060422122441000_fcab035-B41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002093-199903000-00006","article-title":"Sensitivity to semantic cuing: An index of episodic memory dysfunction in early Alzheimer disease","volume":"13","author":"Tounsi","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2021060422122441000_fcab035-B42","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1212\/01.wnl.0000279336.36610.f7","article-title":"Amnestic syndrome of the medial temporal type identifies prodromal AD. A longitudinal study","volume":"69","author":"Sarazin","year":"2007","journal-title":"Neurology"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcab035\/36584542\/fcab035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/2\/fcab035\/38489929\/fcab035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/braincomms\/article-pdf\/3\/2\/fcab035\/38489929\/fcab035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:49:42Z","timestamp":1622854182000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcab035\/6168994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcab035","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,3,12]]},"article-number":"fcab035"}}